Status:
WITHDRAWN
Photo-therapy With a Topical Retinoid Versus Photo-therapy Alone for Actinic Keratoses
Lead Sponsor:
Northwestern University
Conditions:
Actinic Keratoses
Eligibility:
All Genders
18-80 years
Phase:
NA
Brief Summary
Evaluating safety and efficacy of the use of topical retinoid with photodynamic therapy for the treatment of actinic keratoses.
Detailed Description
Evaluating safety and efficacy of the use of topical retinoid with photodynamic therapy vs photodynamic therapy alone for the treatment of actinic keratoses.
Eligibility Criteria
Inclusion
- Inclusion Criteria
- Adults aged 18-80 years old
- Subjects with AK lesions who will receive PDT
- Subjects with AK lesions in two areas other than face and scalp each with a surface area of 10cm2 or greater and at least 3 clinically diagnosed non-hypertrophic AK lesions in each
- Subjects in good health
- Subjects with willingness and the ability to understand and provide informed consent
- Exclusion Criteria
- Subjects who are pregnant or lactating
- Subjects with a history of cutaneous photosensitivity or porphyria, hypersensitivity to porphyrins, or photodermatosis
- Subjects with use of photosensitizing drugs within 1 week of study start
- Subjects with use of topical medications such as corticosteroids, alpha-hydroxyacids or retinoids 2 weeks before study entry
- Subjects who received previous treatment of target AKs within 4 weeks
- Subjects who are unable to understand the protocol or give informed consent
Exclusion
Key Trial Info
Start Date :
March 1 2016
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 1 2017
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT00756288
Start Date
March 1 2016
End Date
December 1 2017
Last Update
December 6 2021
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.